Captopril Compounded Oral Suspension
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Captopril Compounded Oral Suspension contains NLT 90.0% and NMT 110.0% of the labeled amount of captopril (C9H15NO3S).
Prepare Captopril Compounded Oral Suspension 0.75 mg/mL as follows (see Pharmaceutical Compounding—Nonsterile Preparations 〈795〉).
| Captopril | 75mg |
Vehicle: a 1:1 mixture of Vehicle for Oral Solution (regular or sugar-free), NF, and Vehicle for Oral Suspension, NF, a sufficient quantity to make | 100 mL |
Place the required number of tablets in a suitable mortar and comminute to a fine powder, or use Captopril powder. Add 10 mL of Vehicle, and mix to form a uniform paste. Add the Vehicle in small portions, and mix thoroughly after each addition. Transfer the contents of the mortar, stepwise and quantitatively, to a calibrated bottle. Add sufficient Vehicle to bring to final volume, and mix well.
2 ASSAY
2.1 Procedure
Mobile phase: Methanol and water (55:45) containing 0.5 mL/L of phosphoric acid. Filter, and degas.
Standard solution: 7.5 μg/mL of USP Captopril RS
Sample solution: Agitate the container of Oral Suspension for 30 min on a rotating mixer, remove a 5-mL sample, and store in a clear glass vial at −70° until analyzed. At the time of analysis, remove the sample from the freezer, allow it to reach room temperature, and mix with a vortex mixer for 30 s. Pipet 1.0 mL of the sample into a 100-mL volumetric flask, and dilute with Mobile phase to volume.
2.2 Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 220 nm
Column: 4.6-mm × 25-cm; 5-μm packing L1
Flow rate: 1 mL/min
Injection volume: 20 μL
2.3 System suitability
Sample: Standard solution
[Note—The retention time for captopril is about 5.0 min.]
2.4 Suitability requirements
Relative standard deviation: NMT 0.9% for replicate injections
2.5 Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of captopril (C9H15NO3S) in the portion of Oral Suspension taken:
Result = (rU/rS) x (CS/CU) × 100
ru = peak response from the Sample solution
rs = peak response from the Standard solution
Cs = concentration of USP Captopril RS in the Standard solution (μg/mL)
Cu = nominal concentration of captopril in the Sample solution (μg/mL)
Acceptance criteria: 90.0%–110.0%
3 SPECIFIC TESTS
pH 〈791〉: 3.8–4.3
4 ADDITIONAL REQUIREMENTS
Packaging and Storage: Package in tight, light-resistant containers. Store in a refrigerator.
Beyond-Use Date: NMT 7 days after the date on which it was compounded when stored in a refrigerator
Labeling: Label it to indicate that it is to be well shaken before use, and to state the Beyond-Use Date.
USP Reference Standards 〈11〉
USP Captopril RS

